Amplify Surgical
Amplify Surgical innovates surgical systems, enhancing implants and instruments for improved clinical outcomes.
Founded
2017Amplify Surgical innovates surgical systems, enhancing implants and instruments for improved clinical outcomes.
Amplify Surgical was founded with the mission to innovate surgical systems by enhancing implants and instruments for improved clinical outcomes. The company focuses on developing clinically-relevant surgical solutions that transform ordinary implants into systems that deliver successful results, enabling patients to return to their active lives quickly. Their flagship products include the dualX® and dualPortal® systems, which offer advanced expandable interbody fusion and a novel two-portal endoscopic approach to spine surgery, respectively.
Notable figures affiliated with Amplify Surgical include a dedicated leadership team and board of directors who collaborate closely with surgeon partners and a distributor network. The company has achieved significant milestones, including the successful launch and adoption of their dualX® and dualPortal® technologies. Amplify Surgical's impact is evident in the enhanced clinical outcomes and quicker recovery times for patients, positioning them as a transformative force in the surgical systems market.
Companies similar to Amplify Surgical include Innvotec Surgical, Accelus, New View Surgical and Simparo Surgical.
Amplify Surgical was founded in 2017.
Amplify Surgical's headquarters is located in Irvine, CA, US.
Amplify Surgical's most recent funding round was for $7.3M (USD) in October 2018.
As of Oct 3, 2018, Amplify Surgical has disclosed funding of $7.3M (USD). Undisclosed round amounts are excluded.
Amplify Surgical has 12 employees as of Feb 5, 2024.
Simparo Surgical
